United States Pharmaceuticals

Assertio Holdings Inc (ASRT)

Track

The most recent insider trading activity at Assertio Holdings Inc. occurred on November 10, 2025, involving a planned and proposed sale of shares by Director David Stark. No insider transactions have been recorded in the last three months. Previous activity included various buy and sell transactions throughout 2024 and 2023.
Ticker: ASRT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Assertio Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 10 Nov 2025
Value US$3,945,441.29 | Price 219.41 | Shares 50,974 (+0.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-12 2025-11-10 PlS Planned sale
Stark David Matthew
Non-Executive Director
50,974 +0.4%
219.41
US$3,945,441 		50,974 +0.4% 219.41 US$3,945,441
2025-11-10 2025-11-10 PrS Proposed sale
DAVID STARK

Director

Non-Executive Director
73,023
55.51
US$256,302 		73,023 55.51 US$256,302
2024-11-19 2024-11-18 B Purchase
4.0
Mason Heather L
Non-Executive Director
90,680 +16.4%
374.93
US$848,751 		90,680 +16.4% 374.93 US$848,751
2024-11-15 2024-11-14 B Purchase
2.2
O'Grady Brendan P.

CEO

Executive Director
11,706 +inf%
0.85
US$9,950 		11,706 +inf% 0.85 US$9,950
2024-06-12 2024-06-11 B Purchase
2.6
Vacirca Jeff L
Non-Executive Director
10,000 +7.1%
1.11
US$11,100 		10,000 +7.1% 1.11 US$11,100
2024-06-06 2024-06-05 B Purchase
4.0
Mason Heather L

Interim Executive Officer

Executive Director
25,000 +13.3%
0.97
US$24,250 		25,000 +13.3% 0.97 US$24,250
2024-03-15 2024-03-14 S Sale
3.3
Tyree James L
Non-Executive Director
10,251 -5.2%
1.12
US$11,463 		10,251 -5.2% 1.12 US$11,463
2024-03-14 2024-03-14 PrS Proposed sale
3.3
Tyree James L

Director

Non-Executive Director
10,251
1.12
US$11,463 		10,251 1.12 US$11,463
2023-09-13 2023-09-12 S Sale
3.3
Peisert Daniel A.

President & CEO

Executive Director
31,121 -8.7%
2.97
US$92,432 		31,121 -8.7% 2.97 US$92,432
2023-09-12 2023-09-12 PrS Proposed sale
3.3
Daniel A Peisert

Officer

Officer
31,121
3.01
US$93,674 		31,121 3.01 US$93,674
2023-09-13 2023-09-11 S Sale
3.3
Schlessinger Sam

SVP, General Counsel

Officer
45,236 -39.6%
3.04
US$137,441 		45,236 -39.6% 3.04 US$137,441
2023-09-13 2023-09-11 S Sale
3.3
Schwichtenberg Paul

SVP and CFO

Officer
104,980 -62.0%
3.07
US$322,593 		104,980 -62.0% 3.07 US$322,593
2023-09-13 2023-09-11 S Sale
2.7
Patel Ajay

SVP and CAO

Officer
64,313 -40.7%
3.04
US$195,794 		64,313 -40.7% 3.04 US$195,794
2023-09-13 2023-09-11 S Sale
3.3
Peisert Daniel A.

President & CEO

Executive Director
127,281 -26.3%
3.04
US$386,972 		127,281 -26.3% 3.04 US$386,972
2023-09-11 2023-09-11 PrS Proposed sale
2.7
Patel Ajay

Officer

Officer
64,313
3.17
US$203,872 		64,313 3.17 US$203,872
2023-09-11 2023-09-11 PrS Proposed sale
3.3
SAM SCHLESSINGER

Officer

Officer
45,236
3.04
US$137,441 		45,236 3.04 US$137,441
2023-09-11 2023-09-11 PrS Proposed sale
3.3
DANIEL PEISERT

Officer

Officer
127,281
3.04
US$386,972 		127,281 3.04 US$386,972
2023-09-11 2023-09-11 PrS Proposed sale
3.3
PAUL SCHWICHTENBERG

Officer

Officer
104,980
3.07
US$322,593 		104,980 3.07 US$322,593
2023-08-15 2023-08-14 PlS Planned sale
MCKEE WILLIAM
Non-Executive Director
22,000 -8.4%
3.14
US$69,045 		22,000 -8.4% 3.14 US$69,045
2023-08-14 2023-08-14 PrS Proposed sale
WILLIAM MCKEE

Director

Non-Executive Director
22,000
3.14
US$69,045 		22,000 3.14 US$69,045
2023-05-22 2023-05-19 S Sale
4.0
Mason Heather L
Non-Executive Director
89,286 -32.2%
7.30
US$652,011 		89,286 -32.2% 7.30 US$652,011
2023-05-19 2023-05-19 PrS Proposed sale
4.0
Mason Heather L

Director

Non-Executive Director
89,286
7.30
US$651,788 		89,286 7.30 US$651,788
2023-05-05 2023-05-05 PrS Proposed sale
3.3
JAMES TYREE

Director

Non-Executive Director
43,143
6.00
US$258,767 		43,143 6.00 US$258,767
2023-05-05 2023-05-05 PlS Planned sale
3.3
Tyree James L
Non-Executive Director
43,143 -20.5%
6.00
US$258,767 		43,143 -20.5% 6.00 US$258,767
2022-05-16 2022-05-12 PlS Planned sale
MCKEE WILLIAM
Non-Executive Director
22,322 -8.9%
2.35
US$52,488 		22,322 -8.9% 2.35 US$52,488
2022-05-16 2022-05-12 PlS Planned sale
3.3
Tyree James L
Non-Executive Director
44,643 -17.5%
2.36
US$105,170 		44,643 -17.5% 2.36 US$105,170
2022-04-13 2022-04-11 PlS Planned sale
3.3
Peisert Daniel A.

President and CEO

Executive Director
26,391 -14.3%
3.50
US$92,368 		26,391 -14.3% 3.50 US$92,368
2022-04-07 2022-04-05 PlS Planned sale
3.3
Peisert Daniel A.

President and CEO

Executive Director
34,518 -15.7%
3.50
US$120,813 		34,518 -15.7% 3.50 US$120,813
2021-05-24 2021-05-20 B Purchase
2.7
Patel Ajay

SVP and CAO

Officer
8,170 +81.5%
1.53
US$12,500 		8,170 +81.5% 1.53 US$12,500
2021-05-24 2021-05-20 B Purchase
3.3
Schwichtenberg Paul

SVP and CFO

Officer
9,750 +70.8%
1.51
US$14,762 		9,750 +70.8% 1.51 US$14,762
2021-05-24 2021-05-20 B Purchase
3.3
Peisert Daniel A.

President and CEO

Executive Director
15,909 +21.6%
1.54
US$24,500 		15,909 +21.6% 1.54 US$24,500
2020-12-29 2020-12-24 S Sale
3.6
CR Group L.P.
Large shareholder
1,982,851 -90.8%
0.37
US$730,086 		1,982,851 -90.8% 0.37 US$730,086
2020-12-29 2020-12-23 S Sale
3.6
CR Group L.P.
Large shareholder
6,784,334 -75.7%
0.37
US$2,540,733 		6,784,334 -75.7% 0.37 US$2,540,733
2020-12-22 2020-12-22 S Sale
3.6
CR Group L.P.
Large shareholder
1,500,000 -14.3%
0.34
US$508,500 		1,500,000 -14.3% 0.34 US$508,500
2020-12-22 2020-12-21 S Sale
3.6
CR Group L.P.
Large shareholder
500,000 -4.6%
0.36
US$180,100 		500,000 -4.6% 0.36 US$180,100
2020-12-22 2020-12-18 S Sale
3.6
CR Group L.P.
Large shareholder
500,000 -4.4%
0.38
US$188,800 		500,000 -4.4% 0.38 US$188,800
Explore more

More insider trading research around Assertio Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America